LncRNA-NEAT1/miR-506-3p/ZEB2轴调控EMT介导胰腺癌吉西他滨耐药的机制研究
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | ZEB2基因表达变异在胰腺癌化疗预后诊断中的应用 | 专利 | 邹叶青;黄波;付晓伟;王小中 |
2 | E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1 | 期刊论文 | Xueqiang Deng;Xiaowei Fu;Hong Teng;Lu Fang;Bo Liang;Rengui Zeng;Lian Chen;Yeqing Zou |
3 | Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis | 期刊论文 | Xiaowei Fu;Xueqiang Deng;Weidong Xiao;Bo Huang;Xuan Yi;Yeqing Zou |